Spironolactone Tablet
Product Images NDC 71610-970

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71610-970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0970 45)

Label (71610 0970 45)
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
This information describes a clinical trial comparing the effects of Spironolactone to a placebo over different time points, measured in months. The log-rank probability was found to be less than 0.001, indicating a statistically significant difference between the two groups.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This text appears to be a medical chart or graph displaying information related to subgroups, diabetes, creatinine levels, potassium levels, beta-blockers, and the comparison between Spironolactone and Placebo. The chart includes numerical values and possibly treatment outcomes based on the data presented.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.